Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy
Lawin D, Lawrenz T, Marx K, Danielsmeier NB, Poudel MR, Stellbrink C (2022)
Heart .
Zeitschriftenaufsatz
| E-Veröff. vor dem Druck | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Lawin, DennisUniBi;
Lawrenz, ThorstenUniBi;
Marx, Kristin;
Danielsmeier, Nils Benedikt;
Poudel, Madan RajUniBi;
Stellbrink, ChristophUniBi
Einrichtung
Abstract / Bemerkung
OBJECTIVE: Alcohol septal ablation (ASA) improves symptoms in hypertrophic obstructive cardiomyopathy (HOCM). We conducted a large retrospective analysis investigating gender effects on outcome after ASA.; METHODS AND RESULTS: 1367 ASAs between 2002 and 2020 were analysed. Women (47.2%) were older (66.0 years (IQR 55.0-74.0) vs 54.0 years (IQR 45.0-62.0); p<0.0001) with more severe symptoms. The interventricular septal diameter (IVSD) was higher in men (21.0mm (IQR 19.0-24.0) vs 20.0mm (IQR 18.0-23.0); p<0.0001) but the IVSD indexed to body surface area was higher in women (10.9 mm/m2 (IQR 9.7-12.7) vs 10.2 mm/m2 (IQR 9.0-11.7); p<0.0001). Women had lower exercise-induced left ventricular outflow tract gradients (LVOTG) 1-4days after ASA (55.0mm Hg (IQR 30.0-109.0) vs 71.0mm Hg (IQR 37.0-115.0); p=0.0006). There was a trend for lower resting LVOTG 1-4days after ASA (20.0mm Hg (IQR 12.0-37.5) vs 22.0mm Hg (IQR 13.0-40.0); p=0.0062) and lower exercise-induced LVOTG after 6 months in women (34.0mm Hg (IQR 21.0-70.0) vs 43.5mm Hg (IQR 25.0-74.8); p=0.0072), but this was not statistically significant after Bonferroni correction. More women developed atrioventricular (AV) block (20.3% vs 13.3%; p=0.0005) and required a pacemaker (17.4% vs 10.4%; p=0.0002) but not a cardioverter defibrillator (9.0% vs 11.6% in men; p=n.s.). However, in multivariable regression models, there was no evidence that sex independently influenced LVOTG and the occurrence of AV block.; CONCLUSION: Female patients with HOCM were older and had more advanced disease at the time of ASA. Women had superior short-term haemodynamic response to ASA but more often developed AV block after ASA. These results are important to consider for sex-specific counselling before ASA. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Erscheinungsjahr
2022
Zeitschriftentitel
Heart
eISSN
1468-201X
Page URI
https://pub.uni-bielefeld.de/record/2963950
Zitieren
Lawin D, Lawrenz T, Marx K, Danielsmeier NB, Poudel MR, Stellbrink C. Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart . 2022.
Lawin, D., Lawrenz, T., Marx, K., Danielsmeier, N. B., Poudel, M. R., & Stellbrink, C. (2022). Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart . https://doi.org/10.1136/heartjnl-2022-320852
Lawin, Dennis, Lawrenz, Thorsten, Marx, Kristin, Danielsmeier, Nils Benedikt, Poudel, Madan Raj, and Stellbrink, Christoph. 2022. “Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy”. Heart .
Lawin, D., Lawrenz, T., Marx, K., Danielsmeier, N. B., Poudel, M. R., and Stellbrink, C. (2022). Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart .
Lawin, D., et al., 2022. Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart .
D. Lawin, et al., “Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy”, Heart , 2022.
Lawin, D., Lawrenz, T., Marx, K., Danielsmeier, N.B., Poudel, M.R., Stellbrink, C.: Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Heart . (2022).
Lawin, Dennis, Lawrenz, Thorsten, Marx, Kristin, Danielsmeier, Nils Benedikt, Poudel, Madan Raj, and Stellbrink, Christoph. “Gender disparities in alcohol septal ablation for hypertrophic obstructive cardiomyopathy”. Heart (2022).
Daten bereitgestellt von European Bioinformatics Institute (EBI)
Zitationen in Europe PMC
Daten bereitgestellt von Europe PubMed Central.
References
Daten bereitgestellt von Europe PubMed Central.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 35697495
PubMed | Europe PMC
Suchen in